ECJ Competition – Agreements, decisions and concerted practices – Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram – Concept of restriction of competition ‘by object’ – Potential competition – Generic medicinal products – Barriers to market entry resulting from the existence of patents – Agreements concluded between a patent holder and a generic undertaking – Error of law – Error of assessment – Rights of defence – Fines
ECLI:EU:T:2016:454, [2016] EUECJ T-469/13
Bailii
European
Commercial
Updated: 22 January 2022; Ref: scu.569058
